Provider review · verified None
Trimi review: pricing, fine print, and how it ranks
tracked; no published price we could verify — verified None, third-party-reported.
- Tirzepatide (reported, unverified)
- $125/mo — third-party figure; excluded from rankings
- Tirzepatide, all-in at 10 mg
- Offered — no published price
- Semaglutide, all-in
- Not offered
- Membership fee
- None
- Price evidence
- Third-party-reported
The price, in words
Trimi is reported at tirzepatide at $125/mo — figures published by a competing comparison site (May 2026), not read on a provider pricing page we could capture. We list reported figures for completeness and exclude them from every ranking until source verification; our methodology treats an unverifiable low price as a question, not a winner.
What the fine print says
Trimi's ~$125/mo figure is third-party and attached to an annual prepaid plan billed upfront — an effective rate, not a standing monthly price, and unverified at the source. Unranked pending capture; prepaid + unverified is the riskiest combination in this market, so get current terms and refund language in writing.
Pharmacy & transparency
Price evidence: Third-party-reported. The dispensing pharmacy is not named publicly — the single most common transparency gap in this market. Ask which pharmacy fills the prescription, whether it is 503A or 503B, and whether a certificate of analysis is available; our pharmacy guide explains what each answer means.
Nearest alternatives at this price point
If this program's terms don't fit, the same money buys NexLife at $215 (flat at every dose, no membership, named pharmacy); Yucca Health at $258 (flat at every dose, no membership, prepaid to $225); IVIM Health at $278 (source-verified) — each linked matchup runs the full head-to-head arithmetic on this exact question.
State availability
Trimi doesn't publish a state footprint we could capture — confirm your state at intake before anything else. State-by-state context, exceptions, and city coverage live in the 51-state cost guides.
Five questions before checkout
Whatever the marketing says, get answers to: (1) the current all-in monthly price, in writing, since no verifiable figure is published; (2) whether the price changes at any rung of the dose ladder, and the exact tier schedule; (3) which pharmacy, by name, fills the prescription — and whether it's 503A or 503B, licensed for your state, with a certificate of analysis available; (4) the cancellation mechanics — deadline relative to renewal, written-confirmation availability, and whether any membership cancels separately. A program that answers all five plainly has already told you most of what this review can.
Bottom line
Until Trimi publishes verifiable pricing, treat any quoted figure as unconfirmed and get it in writing. For context, the verified market floor is $215/mo compounded tirzepatide and $133/mo compounded semaglutide, with brand Zepbound at $449/mo and Wegovy at $349/mo at maintenance.
Trimi: quick answers
How much does Trimi cost?
Trimi publishes no medication price we could verify; we track it as unpriced. Request current pricing in writing before enrolling.
Does Trimi charge a membership fee?
No separate membership fee; the monthly price is the billed total (before any add-ons you choose).
Is Trimi legit?
Trimi is a real, operating program we track. It sells compounded GLP-1s, which are not FDA-approved and operate under the contested post-shortage pathways described in our legal guide. It does not publicly name its dispensing pharmacy — ask before you buy.